The proposal builds on innovative technologies patented and published by my group. The project has two specific objectives: 1) to deliver the new generation of intelligent biomedical devices that have the capacity to control infections, inflammation and foreign body response; and 2) to develop a novel, non-invasive and affordable point of care diagnostic technology for early detection of chronic kidney diseases, and kidney and bladder cancers that is much needed in this space of healthcare.
Significance Of Low-level Mosaicism To Intellectual Disability In Paediatric Disorders
Funder
National Health and Medical Research Council
Funding Amount
$483,402.00
Summary
My vision for the next 4 years is to improve outcomes for children and their families with inherited disorders associated with intellectual disability (ID) and autism through earlier diagnosis and intervention. This is of great importance with annual costs of ID close $14.72 billion to the Australian health system, and missed or delayed diagnoses being a significant problem, as ID is found in 1.7% of births, where a specific cause is currently identified in less than half.
Novel Interventions For Comprehensive Prevention Of Mother-to-child Transmission Of HIV-1 In Resource-constrained Settings
Funder
National Health and Medical Research Council
Funding Amount
$474,034.00
Summary
Nearly 2.5 million persons are infected with HIV each year. My vision is to improve the health of vulnerable women and children in resource-constrained settings through comprehensive prevention of mother-to-child transmission of HIV-1. This work aims to i) prevent HIV among women of childbearing age; ii) prevent unintended pregnancies among HIV-infected women; iii) prevent transmission of HIV from mothers to their infants; and iv) provide treatment, care and support for those living with HIV.
Central Blood Pressure: Physiology And Clinical Application
Funder
National Health and Medical Research Council
Funding Amount
$459,270.00
Summary
Current methods used by doctors to measure blood pressure (BP) have many limitations that could result in incorrect diagnosis and inappropriate treatment of high BP (hypertension). This research program will determine the clinical usefulness of new methods to diagnose and treat people with high BP. The underlying mechanisms contributing to high BP will also be examined. The findings will lead to improved ways to identify and more effectively manage people with high BP.
Development Of Genomic Tools For Precision Medicine In Infectious Disease And Cancer
Funder
National Health and Medical Research Council
Funding Amount
$470,144.00
Summary
I will develop tools for precision medicine in cancer and infectious disease. In infectious disease, these tools will provide rapid diagnosis of bacterial infection as well as the characterization of drug resistance, which will mean clinicians can give the correct antibiotic the first time. In cancer, it will provide tools for identifying the type of cancer present in a patient, and for identifying the likely response to different treatment options on the basis of which genes are switched-on
Vestibulo-ocular Reflex Physiology, Pathology And Rehabilitation
Funder
National Health and Medical Research Council
Summary
A sensation of movement from the inner ear is used to stabilise vision during head movements. Without it, every time you walk, run, or drive on a bumpy road, the world would appear to bounce. It can be debilitating when this sense doesn't work due to various diseases. This research examines how this sense works normally and the factors important for self-repair after injury. This work will also develop training exercises using a device for take-home balance rehabilitation.
Advanced Technologies For Improved Molecular Diagnostic And Prognostic Of Gastrointestinal Cancers
Funder
National Health and Medical Research Council
Funding Amount
$473,477.00
Summary
The aim of this interdisciplinary research is to develop innovative and clinically relevant technologies for improved molecular diagnostic of gastrointestinal cancers. It integrates technological advances in physics, bioengineering and nanoscience with state-of-the-art molecular technologies towards the delivery of both fundamental and translational outcomes. These technologies will be applied to address important fundamental questions such as the role of circulating tumour cells.
My research team is focused on human parasites of major relevance to the Australian water industry and/or global public health. Our primary focus is the use of advanced technologies to improve understanding of these parasites and to utilize this information to underpin development of new drugs to treat them and novel diagnostic tests to improve their control.
My research objectives centre on new technology development for improving diagnostics and therapeutics applied to skin. I have developed and patented novel devices for minimally invasive topical drug delivery and skin sampling. My leadership and tangible research outcomes are now enabling previously impossible skin research to be done and now are also impacting the commercial sector in addition to creating new knowledge in the field.